Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Bioluminescence imaging has previously been used to monitor the formation of grafted tumors in vivo and measure cell number during tumor progression and response to therapy. The development and optimization of successful cancer therapy strategies may well require detailed and specific assessment of biological processes in response to mechanistic intervention. Here, we use bioluminescence imaging to monitor the cell cycle in a genetically engineered, histologically accurate model of glioma in vivo. In these platelet-derived growth factor (PDGF)-driven oligodendrogliomas, G1 cell-cycle arrest is generated by blockade of either the PDGF receptor or mTOR using small-molecule inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PDGF/ERK signalling activates cell cycle regulators to stimulate proliferation24,25, and βPDGFRαTg islets had elevated levels of Ccnd1 mRNA encoding cyclin D1, and increased β-cells with nuclear cyclin D1 and phosphorylated Rb protein (Fig. 5c–e and Supplementary Fig. 9a).”
From PDGF signalling controls age-dependent proliferation in pancreatic β-cells (2011) · cites this paper as [24]
Citations
Cites
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2
Garami, A., Zwartkruis, F. J. T., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S. C., Hafen, E., Bos, J. L., & Thomas, G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00220-x · Cited by 1,043
Dai, C., Celestino, J. C., Okada, Y., Louis, D. N., Fuller, G. N., & Holland, E. C. (2001) · Genes & Development · doi:10.1101/gad.903001 · Cited by 708
Self-citationAn inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/−mice
Podsypanina, K., Lee, R. T., Politis, C., Hennessy, I., Crane, A., Puc, J., Neshat, M., Wang, H., Yang, L., Gibbons, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171060098 · Cited by 569
Visualizing Gene Expression in Living Mammals Using a Bioluminescent Reporter
Contag, C. H., Spilman, S. D., Contag, P. R., Oshiro, M., Eames, B., Dennery, P., Stevenson, D. K., & Benaron, D. A. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb03184.x · Cited by 526
Bioluminescent indicators in living mammals
Contag, P. R., Olomu, I. N., Stevenson, D. K., & Contag, C. H. (1998) · Nature Medicine · doi:10.1038/nm0298-245 · Cited by 517
Johnson, D. G., Ohtani, K., & Nevins, J. R. (1994) · Genes & Development · doi:10.1101/gad.8.13.1514 · Cited by 494
Gliomagenesis: genetic alterations and mouse models
Holland, E. C. (2001) · Nature Reviews Genetics · doi:10.1038/35052535 · Cited by 461
Self-citationRapid and Quantitative Assessment of Cancer Treatment Response Using In Vivo Bioluminescence Imaging
Rehemtulla, A., Stegman, L. D., Cardozo, S. J., Gupta, S., Hall, D. E., Contag, C. H., & Ross, B. D. (2000) · Neoplasia · doi:10.1038/sj.neo.7900121 · Cited by 460
Rajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00395-2 · Cited by 420
Self-citationTumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G., & Fine, H. A. (1997) · Nature Medicine · doi:10.1038/nm1097-1145 · Cited by 169
Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging
Choy, G., O’Connor, S., Diehn, F. E., Costouros, N., Alexander, H. R., Choyke, P., & Libutti, S. K. (2003) · BioTechniques · doi:10.2144/03355rr02 · Cited by 168
Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo
Shah, K., Tang, Y., Breakefield, X. O., & Weissleder, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206748 · Cited by 131
Time Course of Bioluminescent Signal in Orthotopic and Heterotopic Brain Tumors in Nude Mice
Burgos, J. S., Rosol, M. S., Moats, R. A., Khankaldyyan, V., Kohn, D. B., Nelson, M. D., & Laug, W. E. (2003) · BioTechniques · doi:10.2144/03346st01 · Cited by 104
Rehemtulla, A., Hall, D. E., Stegman, L. D., Prasad, U., Chen, G., Bhojani, M. S., Chenevert, T. L., & Ross, B. D. (2002) · Molecular Imaging · doi:10.1162/153535002753395707 · Cited by 101
Dai, C., Lyustikman, Y., Shih, A. H., Hu, X., Fuller, G. N., Rosenblum, M. K., & Holland, E. C. (2005) · Neoplasia · doi:10.1593/neo.04691 · Cited by 63
Self-citationIn vivo imaging of molecular-genetic targets for cancer therapy
Gelovani, J. G., & Blasberg, R. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00082-5 · Cited by 51
Research works printed but not linked: 1
- Shih, A. et al. Dose dependent effects of PDGF-B on glial tumorigenesis. Cancer Res. (in press).
Cited by
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
Self-citationMaximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
Illuminating the metastatic process
Sahai, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2229 · Cited by 569
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
Zhang, F., Parayath, N. N., Ene, C. I., Stephan, S. B., Koehne, A. L., Coon, M. E., Holland, E. C., & Stephan, M. T. (2019) · Nature Communications · doi:10.1038/s41467-019-11911-5 · Cited by 521
Self-citationMonitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
Burd, C. E., Sorrentino, J. A., Clark, K. S., Darr, D. B., Krishnamurthy, J., Deal, A. M., Bardeesy, N., Castrillon, D. H., Beach, D. H., & Sharpless, N. E. (2013) · Cell · doi:10.1016/j.cell.2012.12.010 · Cited by 419
“In contrast, several “tumor-specific” reporter alleles have been reported in the literature (e.g., E2f-LUC [Uhrbom et al., 2004], ARF-GFP [Zindy et al., 2003], ODD-Luc [Goldman et al., 2011; Safran et al., 2006], and p21-p-luc [Ohtani et al., 2007]), but these models are not ideal as they are…”
Metadata
- Authors
- Uhrbom, L., Nerio, E., & Holland, E. C.
- Affiliations
- Uppsala University (SE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Holland, Eric C
- Venue
- Nature Medicine
- Published
- 2004-10-24
- Volume
- 10
- Issue
- 11
- Pages
- 1257-1260
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2034345257
- Cited by
- 146
- References
- 18
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 4 · 2013: 13 · 2012: 7
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › bioluminescence and chemiluminescence research
- Keywords
- glioma, bioluminescence imaging, cell proliferation, cell cycle, G1 cell cycle arrest, platelet-derived growth factor, PDGF receptor, mTOR inhibition, genetically engineered mouse models, tumor maintenance, oligodendroglioma
- MeSH terms
- Animals, Cell Cycle, Disease Models, Animal, DNA-Binding Proteins, Immunohistochemistry, Luciferases, Luminescent Measurements, Mice, Transgenic, Oligodendroglioma, Phthalazines, Platelet-Derived Growth Factor, Promoter Regions, Genetic, Protein Kinases, Pyridines, Transcription Factors, DNA Primers, Cell Cycle Proteins, In Situ Nick-End Labeling, Receptor, Platelet-Derived Growth Factor alpha, E2F Transcription Factors, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.